BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Treatment
8144 results:

  • 1. Impact of an Inter-Professional Clinic on pancreatic cancer Outcomes: A Retrospective Cohort Study.
    Moffat GT; Coyne Z; Albaba H; Aung KL; Dodd A; Espin-Garcia O; Moura S; Gallinger S; Kim J; Fraser A; Hutchinson S; Moulton CA; Wei A; McGilvray I; Dhani N; Jang R; Elimova E; Moore M; Prince R; Knox J
    Curr Oncol; 2024 May; 31(5):2589-2597. PubMed ID: 38785475
    [No Abstract]    [Full Text] [Related]  

  • 2. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
    Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
    Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
    Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
    Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.
    Yamada R; Kuriyama N; Tanaka T; Nose K; Nakamura Y; Miwata T; Tsuboi J; Mizuno S; Nakagawa H
    BMC Gastroenterol; 2024 May; 24(1):174. PubMed ID: 38769494
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
    Wang J; Lin J; Wang R; Tong T; Zhao Y
    BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for pancreatic Ductal Adenocarcinoma.
    Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
    Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
    [No Abstract]    [Full Text] [Related]  

  • 7. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Enrichment and Evaluation of Antitumor Properties of Total Flavonoids from
    Yang S; Chu G; Wu J; Zhang G; Du L; Lin R
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731467
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Translational PET Imaging of Nectin-4 Expression in Multiple Different cancers with
    Zhang J; Duan X; Chen X; Zhang Z; Sun H; Shou J; Zhao G; Wang J; Ma Y; Yang Y; Tian X; Shen Q; Yu W; He Z; Fan Y; Yang X
    J Nucl Med; 2024 May; 65(Suppl 1):12S-18S. PubMed ID: 38719240
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
    Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
    Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Lin KY; Chen PS; Lin CF
    BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
    Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
    Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Burris HA; Okusaka T; Vogel A; Lee MA; Takahashi H; Breder V; Blanc JF; Li J; Bachini M; Żotkiewicz M; Abraham J; Patel N; Wang J; Ali M; Rokutanda N; Cohen G; Oh DY
    Lancet Oncol; 2024 May; 25(5):626-635. PubMed ID: 38697156
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. NRDE2 deficiency impairs homologous recombination repair and sensitizes hepatocellular carcinoma to PARP inhibitors.
    Wang Y; Liu X; Zuo X; Wang C; Zhang Z; Zhang H; Zeng T; Chen S; Liu M; Chen H; Song Q; Li Q; Yang C; Le Y; Xing J; Zhang H; An J; Jia W; Kang L; Zhang H; Xie H; Ye J; Wu T; He F; Zhang X; Li Y; Zhou G
    Cell Genom; 2024 May; 4(5):100550. PubMed ID: 38697125
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
    Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
    Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Failure to Undergo Resection Following Neoadjuvant Therapy for Resectable pancreatic cancer: A Secondary Analysis of SWOG S1505.
    Cloyd JM; Colby S; Guthrie KA; Lowy AM; Chiorean EG; Philip P; Sohal D; Ahmad S
    J Natl Compr Canc Netw; 2024 Apr; 22(4):. PubMed ID: 38688309
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Structural characterization of the polysaccharide from the black crystal region of Inonotus obliquus and its effect on AsPC-1 and SW1990 pancreatic cancer cell apoptosis.
    Ding M; Yang Y; Zhang Z; Liu H; Dai Y; Wang Z; Ma S; Liu Y; Wang Q
    Int J Biol Macromol; 2024 May; 268(Pt 2):131891. PubMed ID: 38677687
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of data transfer between treatment planning systems on dosimetric parameters.
    Meffe G; Votta C; Turco G; Chillè E; Nardini M; Romano A; Chiloiro G; Panza G; Galetto M; Capotosti A; Moretti R; Gambacorta MA; Boldrini L; Indovina L; Placidi L
    Phys Med; 2024 May; 121():103369. PubMed ID: 38669811
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 408.